
    
      The contrast analysis is separately done on Raltitrexed plus oxaliplatin and 5-fluorouracil
      plus oxaliplatin;Raltitrexed plus irinotecan and 5-fluorouracil plus irinotecan.To
      investigate the objective response rate,the R0 resection rate, the early tumor shrinkage
      （ETS）and depth of response(DPR) and the safety profile.
    
  